Salivary Duct Stenosis: Short-term Symptom Outcomes After Sialendoscopy-assisted Salivary Duct Surgery
Overview
Affiliations
Objectives: To prospectively assess short-term symptom change after sialendoscopy-assisted salivary duct surgery (SASDS) for salivary duct stenosis.
Study Design: Prospective cohort study.
Methods: Patients with obstructive sialadenitis from duct stenosis completed the 20-item Chronic Obstructive Sialadenitis Symptoms (COSS) Questionnaire (scored 0-100) prior to SASDS and 3 months postoperatively.
Results: Thirty glands in 19 patients with endoscopically confirmed salivary duct stenosis showed overall symptom improvement, with a mean COSS score reduction of 12.9 points (standard deviation [SD] 13.1) to a mean postoperative score of 25.1 (range 0-75.5) (P < 0.001) with six (20%) glands (5 patients) achieving complete symptom resolution. Symptoms improved significantly for parotid glands (n = 20) by 16.6 points (SD 15.9) (P < 0.0001). For distal duct stenoses (n = 25), significant symptom improvement was seen in cases treated with dilation only (n = 17; partial stenoses) with a mean 20.6 point COSS reduction (SD 19.0) (P < 0.0005) and in cases treated with sialodochoplasty (n = 5; 4 complete, 1 partial stenosis) with a mean 13.8 point reduction (SD 4.7) (P < 0.005). Symptom scores did not improve after SASDS in proximal stenoses (n = 3) and distal stenoses cases not amenable to treatment (n = 3).
Conclusion: SASDS for salivary duct stenosis often can improve obstructive salivary symptoms; however, many patients report persistent symptoms after surgery. Partial duct stenoses or distal duct stenoses are associated with the greatest improvements in COSS scores after SASDS.
Level Of Evidence: 4. Laryngoscope, 127:2770-2776, 2017.
A Prospective Study of Recovery of Salivary Gland Function After Calculus Removal by Sialendoscopy.
Lakshmi Nair S, Faizal B, Hari H Indian J Otolaryngol Head Neck Surg. 2023; 75(1):88-93.
PMID: 37007899 PMC: 10050491. DOI: 10.1007/s12070-023-03526-6.
Lee S, Kim E, Lee S, Chun Y, Song I, Jun S Maxillofac Plast Reconstr Surg. 2022; 44(1):34.
PMID: 36279018 PMC: 9590517. DOI: 10.1186/s40902-022-00360-8.
Development of a patient reported outcome instrument for chronic sialadenitis.
Ramazani F, Hamour A, Jeffery C, Biron V, Alrajhi Y, OConnell D J Otolaryngol Head Neck Surg. 2022; 51(1):4.
PMID: 35120574 PMC: 8815140. DOI: 10.1186/s40463-022-00555-z.
Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire: An International Consensus.
Buchholzer S, Faure F, Tcheremissinoff L, Herrmann F, Lombardi T, Ng S Laryngoscope. 2021; 132(2):322-331.
PMID: 34236085 PMC: 9291943. DOI: 10.1002/lary.29731.
Botulinum toxin for chronic parotid sialadenitis: A case series and systematic review.
Strohl M, Chang C, Ryan W, Chang J Laryngoscope Investig Otolaryngol. 2021; 6(3):404-413.
PMID: 34195360 PMC: 8223475. DOI: 10.1002/lio2.558.